metricas
covid
Annals of Hepatology Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2...
Journal Information

Statistics

Follow this link to access the full text of the article

Brief report
Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021
Stephen E. Conglya,b,c,
Corresponding author
secongly@ucalgary.ca

Corresponding author.
, Mayur Brahmaniaa,b, Carla S. Coffind,e
a Divisions of Gastroenterology and Hepatology and Medical Transplant, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
b O'Brien Institute of Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
c Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
d Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute, University of Calgary, Calgary, AB, Canada
e Division of Gastroenterology and Hepatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Read
1029
Times
was read the article
229
Total PDF
800
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 16 9 25
2025 11 72 41 113
2025 10 57 22 79
2025 9 41 28 69
2025 8 62 20 82
2025 7 65 9 74
2025 6 38 3 41
2025 5 47 4 51
2025 4 39 2 41
2025 3 46 9 55
2025 2 46 4 50
2025 1 47 11 58
2024 12 35 5 40
2024 11 32 6 38
2024 10 19 3 22
2024 9 27 7 34
2024 8 28 11 39
2024 7 26 6 32
2024 6 19 6 25
2024 5 38 23 61
Show all

Follow this link to access the full text of the article